Delivery Order SPE2DB22D1002-SPE2DB24FLFF4

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of medical products. The $1,679.08 firm fixed-price contract has a period of performance through January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of medical products and supplies. The contract, valued at $597,775.17, has an ultimate completion date of October 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a range of medical products and pharmaceuticals. The contract has a ceiling value of $10,750.82 and a performance period extending through May 6, 2025. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999.00 and in effect through...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $70,093.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, awarded on August 5, 2024, has an ultimate completion date of August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The $21,109.50 firm fixed-price contract has an ultimate completion date of August 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
The U.S. government's Defense Logistics Agency (DLA) awarded a $7,357.18 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, with a completion date of February 11, 2025, is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $1,560.48. The contract is a firm fixed price agreement for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, with a ceiling value of $14,466.60, is for the supply of various pharmaceutical products and medical supplies to support military treatment facilities and federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $14,305.38 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This contract is a part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. Under this larger IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $496,934.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLFF4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of 24,000 units of a capsule product. The fixed-price contract has a ceiling value of $2,313.60 and a completion date of July 23, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:47 AM